DE69413090D1 - Verwendung von 5-Amino-Phthaloylhydrazid als antihypoxisches und defensives Mittel - Google Patents

Verwendung von 5-Amino-Phthaloylhydrazid als antihypoxisches und defensives Mittel

Info

Publication number
DE69413090D1
DE69413090D1 DE69413090T DE69413090T DE69413090D1 DE 69413090 D1 DE69413090 D1 DE 69413090D1 DE 69413090 T DE69413090 T DE 69413090T DE 69413090 T DE69413090 T DE 69413090T DE 69413090 D1 DE69413090 D1 DE 69413090D1
Authority
DE
Germany
Prior art keywords
hypoxic
amino
defensive agent
phthaloyl hydrazide
defensive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69413090T
Other languages
English (en)
Other versions
DE69413090T2 (de
Inventor
Lonid Minin
Slava Saizev
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
"THE CENTER OF MODERN MEDICINE" MEDICOR LTD., MOSK
Original Assignee
L I M A D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L I M A D Ltd filed Critical L I M A D Ltd
Application granted granted Critical
Publication of DE69413090D1 publication Critical patent/DE69413090D1/de
Publication of DE69413090T2 publication Critical patent/DE69413090T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Paints Or Removers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69413090T 1993-02-19 1994-02-12 Verwendung von 5-Amino-Phthaloylhydrazid als antihypoxisches und defensives Mittel Expired - Lifetime DE69413090T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH531/93A CH683966A5 (it) 1993-02-19 1993-02-19 Composti della classe dei ftalidrazidici come sostanze attive in agenti anti-ipossici e di difesa.

Publications (2)

Publication Number Publication Date
DE69413090D1 true DE69413090D1 (de) 1998-10-15
DE69413090T2 DE69413090T2 (de) 1999-08-19

Family

ID=4189148

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69413090T Expired - Lifetime DE69413090T2 (de) 1993-02-19 1994-02-12 Verwendung von 5-Amino-Phthaloylhydrazid als antihypoxisches und defensives Mittel

Country Status (7)

Country Link
US (1) US5512573A (de)
EP (1) EP0612733B1 (de)
JP (1) JP2725994B2 (de)
AT (1) ATE170847T1 (de)
CH (1) CH683966A5 (de)
DE (1) DE69413090T2 (de)
ES (1) ES2125361T3 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH683965A5 (it) * 1993-02-19 1994-06-30 Limad Marketing Exp & Imp Composti della classe dei ftalidrazidici come sostanza attiva in agenti antinfiammatori ed antitossici.
DE60142541D1 (de) 2000-03-28 2010-08-26 Abidov Musea Tazhudinovich Arzneimittel und dessen herstellungsprozess
US7326690B2 (en) * 2002-10-30 2008-02-05 Bach Pharma, Inc. Modulation of cell fates and activities by phthalazinediones
US6953799B1 (en) * 2002-10-30 2005-10-11 Bach Pharma, Inc. Modulation of cell fates and activities by diketo phthalazines
US8592421B2 (en) 2003-08-04 2013-11-26 Valery Khazhmuratovich Zhilov Cyclic bioisosters of purine system derivatives and a pharmaceutical composition based thereon
PL231885B1 (pl) * 2009-01-16 2019-04-30 Abidopharma Spolka Z Ograniczona Odpowiedzialnoscia Sposób wytwarzania soli 5-amino-2,3-dihydroftalazyno-1,4-di onu z metalami alkalicznymi, ich kompozycje farmaceutyczne i ich zastosowanie
EP2393361B1 (de) 2009-02-06 2016-12-07 Bach Pharma, Inc. Pharmazeutisch reine phthalazindione, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
PT2542535E (pt) * 2010-03-01 2014-08-25 Metriopharm Ag Formas cristalinas para sal de sódio de 5-amino-2,3-di hidroftalazino-1,4-diona, preparações farmacêuticas contendo o mesmo e processo para a produção das ditas formas
CN102382115B (zh) * 2011-10-14 2014-06-11 浙江工业大学 一种吲唑并酞嗪化合物的合成方法
RU2532128C1 (ru) * 2013-05-22 2014-10-27 Закрытое акционерное общество "Управляющая компания "Световит" Способ получения о-люминолятов щелочных металлов
US10258620B2 (en) 2014-12-18 2019-04-16 Metriopharm Ag Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said form
CN115536594A (zh) * 2016-02-16 2022-12-30 麦翠奥制药公司 5-氨基-2,3-二氢噻嗪-1,4-二酮的结晶体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2420702A (en) * 1944-06-28 1947-05-20 British Celanese Amino-aliphatic hydrazines and process for making same
US3007937A (en) * 1959-06-04 1961-11-07 Du Pont Synthesis of 5-(4-aminobutyl) hydantoin
BE733845A (de) * 1968-06-12 1969-11-03
US3870792A (en) * 1972-07-24 1975-03-11 Michiro Inoue Certain dihydrophthalizines for treating hemorrhage and thrombosis
US4318505A (en) * 1980-08-12 1982-03-09 Cordell Jr Charles E Disposable suitcase
WO1982000641A1 (en) * 1980-08-25 1982-03-04 Ab Kabivitrum Peptide substrates for determination of protease activity
HU181184B (en) * 1980-09-12 1983-06-28 Eszakmagyar Vegyimuevek Composition for replacing kinetine,the effect and membraneactivity of which is similar to citokinine,which composition improves plant productivity,quantity of protein-nitrogen and anion-absorptivity

Also Published As

Publication number Publication date
JP2725994B2 (ja) 1998-03-11
EP0612733A1 (de) 1994-08-31
ES2125361T3 (es) 1999-03-01
CH683966A5 (it) 1994-06-30
DE69413090T2 (de) 1999-08-19
EP0612733B1 (de) 1998-09-09
JPH07188022A (ja) 1995-07-25
ATE170847T1 (de) 1998-09-15
US5512573A (en) 1996-04-30

Similar Documents

Publication Publication Date Title
DE69413090D1 (de) Verwendung von 5-Amino-Phthaloylhydrazid als antihypoxisches und defensives Mittel
ATE141131T1 (de) Fungizide wirkstoffkombinationen
KR910019620A (ko) 15-케토-프로스타글란딘 화합물을 사용한 췌장 질병의 치료
DE69322912T2 (de) Kosmetisches und/oder Nahrungsmittel enthaltend eine nicht-verseifbare Fraktion von Sesamöl und Vitamin-E
DE69023980T2 (de) 2-(RS)-substituierte-2,3-dihydro-5-oxy-4,6,7-trimethyl-benzofurane, verwendbar als antioxydante Arzneimittel mit mukoregulierender und anti-ischemischer Wirkung.
ES2058343T3 (es) Piridinas disubstituidas.
DK0638068T3 (da) Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner
DK0458589T3 (da) Behandling af okulær hypertension med en okulær synergistisk kombination
DE3779777D1 (de) Aromatische verbindungen mit amider struktur, derivate von aminobenzoesaeuren, hydroxybenzoesaeuren, zimtsaeuren, urocansaeuren und benzimidazolen, die uvb und/oder uva absorbieren.
FI934565A0 (fi) Pyrimidinderivat foer att oeka antitumoeraktiviteten
DK0458590T3 (da) Behandling af okulær hypertension med en synergistisk konbination
DE69205920D1 (de) Modulation eines Injektionslasers.
DE69230644D1 (de) Verwendung von protease nexin-i als mittel gegen entzündungen
DE59006159D1 (de) Verwendung von macrolactonen als antiallergica.
ATE82124T1 (de) Anwendung von n-(2-(diaethylamino)aethyl>-2-methoxy-4((1-h-4,5ihydro-2-imidazolyl)amino>-5- chlorobenzamid als anxiolytisches und antipsychotisches mittel.
ATE187430T1 (de) In position 10 substituierte 1,8-dihydroxy-9(10h)-anthracenon pharmazeutika
ATE97811T1 (de) Antipsychotisch wirksames imidazobenzodiazepin.
DE69725287D1 (de) Indolderivate und wurzelbildende mittel, die diese als aktive bestandteile enthalten
DE573635T1 (de) Zusammensetzung und Verwendung von substituierten 1,3-Dithiolo- und 1,4-Dithiino-Chinoxalinen als Antimikrobielle Mittel.
DK435089A (da) Anvendelse af zofenopril til behandling af rheumatoid arthritis
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
ATE185273T1 (de) Galenische zubereitungen von molsidomin
DK0629407T3 (da) Anvendelse af humant protein C til forhindring og behandling af afsætninger af thrombocytter
DE60030710D1 (de) Freisetzungsregulierende zubereitungen

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8327 Change in the person/name/address of the patent owner

Owner name: MEDINKOR ZMM AG, ZUG, CH

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: "THE CENTER OF MODERN MEDICINE" MEDICOR LTD., MOSK